Skip to main content

Review of HLA tables

Proposal Overview

Status: Board Approved

Sponsoring Committee: Histocompatibility Committee

Strategic Goal 3: Improve waitlisted patient, living donor, and transplant recipient outcomes

Effective date: Pending implementation and notice to members

Policy notice (PDF - 677 K; 12/2017)

Board-approved policy language

Histocompatibility Committee Board briefing paper (PDF - 353 K; 12/2017)